Bone pain palliation with 85Sr therapy

Journal of Nuclear Medicine

Volumn 40, Issue 4, 1999, Pages 585-590

  Giammarile, Francesco ^a   Mognetti, Thomas ^a   Blondet, Cyrille ^a   Desuzinges, Claude ^a   Chauvot, Paul ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

85Sr; Bone pain palliation; Radionuclide therapy

Indexed keywords

STRONTIUM 85;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PALLIATIVE THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TREATMENT INDICATION; TREATMENT OUTCOME;

BONE NEOPLASMS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN, INTRACTABLE; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; STRONTIUM; STRONTIUM RADIOISOTOPES;

EID: 0032938463     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pecher C. Biological investigations with radioactive calcium and strontium. Proc Soc Exp Biol Med. 1941;46:86-91.
2. Laing AH, Ackery DM, Bayly RJ, et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radial. 1991;64:816-822.
3. Breen SL, Powe JE, Porter AT. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma. J Nucl Med. 1992;33:1316-1323.
4. Mertens WC, Stitt L, Porter AT. Strontium-89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship? Am J Clin Oncot. 1993;16:238-242.
5. Porter AT, Davis LP. Systemic radionuclide therapy of bone metastases with strontium-89. Oncology. 1994;8:93-96.
6. Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol. 1994;31:33-40.
7. Robinson RG, Preston DF, Schiefelbein M, Baxter KG. Strontium-89 therapy for the palliation of pain due to osseous metastases. JAMA. 1995;274:420-424.
8. Malmberg I, Persson U, Ask A, Tennvall J, Abrahamsson PA. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy. Urology. 1997;50:747-753.
9. Maxon HR, Deutsch EA, Thomas SR, et al. Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology. 1988;166:501-507.
10. Singh A, Holmes RA, Farhangi M, et al. Human pharmacokinetics of samarium 153 EDTMP in metastatic cancer. J Nucl Med. 1989;30:1814-1818.
11. Atkins HL, Mausner LF, Srivastava SC, et al. Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases. Radiology. 1993;186:279-283.
12. 85Sr radiotherapy of painful bone metastases]. Bulletin ACOMEN. 1988;3:193-196.
13. Spencer R, Herbert R, Rish MW, Little WA. Bone scanning with 85-Sr, 87m-Sr and 18-F. Physical and radiopharmaceutical considerations and clinical experience in 50 cases. Br J Radiol. 1967;40:641-654.
14. Maxfield WS, Watson JD Jr. Strontium-85 bone scans as an aid in the selection of patients for phosphorus-32 therapy of skeletal metastasis. J Nucl Med. 1967;8: 390.
15. Faber DD, Wahman GE, Bailey TA, Flocks RH, Culp DA, Morrison RT. An evaluation of the strontium-85 scan for the detection and localization of bone metastases from prostatic carcinoma: a preliminary report of 93 cases. J Urol. 1967;97:526-532.
16. 85Sr with scintillation camera and whole-body scanner. J Nucl Med. 1968;9:517-522.
17. Volkert WA, Goeckeler WF, Ehrhardt GJ, Ketring AR. Therapeutic radionuclides: productions and decay property considerations. J Nucl Med. 1991;32:174-185.
18. 89Sr for bone metastases. J Nucl Biol Med. 1993;37:38-44.
19. de Klerk JMH, van het Schip AD, Zonnenberg BA, et al. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. J Nucl Med. 1994;35:1423-1428.
20. Silberstein EB, Williams C. Strontium-89 therapy for the pain of osseous metastases. J Nucl Med. 1985;26:345-348